tiprankstipranks
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ:TSHA
US Market
TSHA
Taysha Gene Therapies
RESEARCH TOOLSreports

Taysha Gene Therapies (TSHA) Cash flow

1,247 Followers

Taysha Gene Therapies Cash Flow

TSHA's free cash flow for Q4 2025 was $-26.97M. For the 2025 fiscal year, TSHA's free cash flow was decreased by $-12.23M and operating cash flow was $-26.72M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Mar 22
Operating Cash Flow
$ -93.09M$ -81.22M$ -73.02M$ -88.39M$ -117.04M
Investing Cash Flow
$ -604.00K$ -363.00K$ -7.35M$ -24.93M$ -21.55M
Financing Cash Flow
$ 274.59M$ 76.68M$ 136.39M$ 52.10M$ 39.08M
End Cash Position
$ 322.53M$ 141.64M$ 146.54M$ 90.52M$ 151.74M
Free Cash Flow
$ -93.83M$ -81.60M$ -80.39M$ -113.26M$ -138.60M
Currency in USD

Taysha Gene Therapies Cash Flow